Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL February 2025 Clinical trials Read more
2021 October Editor's pick RELEVANT LITERATURE FOR YOUR DAILY PRACTICE SELECTED BY: GREGOR VERHOEF Read more
2021 October Clinical trials All-trans retinoic acid plus high-dose dexamethasone in patients with newly diagnosed ITP Read more
2021 October Clinical practice Combination regimen effective in patients with R/R classical Hodgin Lymphoma Read more
2021 October Clinical trials Daratumumab maintenance therapy in patients with newly diagnosed MM who received ASCT Read more
2021 October Pharma News Long-term clinical outcomes of tisagenlecleucel in the JULIET trial Read more
2021 October Science CEBPA-bZip mutations are associated with favourable prognosis in de novo AML Read more
Top
